Quantitative assays of epidermal growth factor receptor in human breast cancer: Cut‐off points of clinical relevance
Authors:
- 15 July 1988
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 42 (1) , 36-41
Abstract
Epidermal growth factor receptor (EGFr) assays were performed by 3 different methods on 246 human primary breast carcinomas. Scatchard analyses of multipoint binding data on 19 of the first 209 tumours, performed by a displacement method, demonstrated that the majority of tumours exhibited 2 classes of binding site, the high-affinity site with an affinity constant (KD) of mean 2 nmol/l (SD 1.3, range 0.44-7 nmol/l), and a low-affinity site, KD mean 9.5 nmol/l (range 6–15.5 nmol/l). Scatchard analysis of multipoint assays using increasing concentrations of 125I-labelled EGF showed that saturation of the high-affinity site occurred in the majority of tumours at a concentration of labelled EGF of 1 nM. Comparison of the KD values of the high-affinity site obtained from displacement assays with those obtained by increasing labelled EGF showed that the KD was significantly higher (p = 0.0002) when measured by the latter method. There was no difference in binding capacity of the high-affinity or low-affinity sites by the 2 methods. A 2-point assay with 1 nM labelled EGF (specific activity approx. 80–130 μCi/μg) correlated with quantitative values for the high-affinity site from Scatchard analysis (p < 0.02). There was a strong inverse relationship between EGFr > 10 fmol/mg membrane protein (2-point assay) and ER (dextran-coated charcoal method), Chi-squared 2 × 2 contingency table test = 34.027, p < 0.0001. Follow-up data from 135 patients revealed a strong inverse relationship between EGFr > 10 fmol/mg membrane protein and oestrogen receptor (ER) status and a positive correlation with early recurrence and death. Our data describe a reproducible assay for EGFr and show that a cut-off point at 10 fmol/mg allows clinically useful application.Keywords
This publication has 20 references indexed in Scilit:
- Autocrine and paracrine growth regulation of human breast cancerBreast Cancer Research and Treatment, 1986
- Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer.Journal of Clinical Pathology, 1985
- EPIDERMAL-GROWTH-FACTOR RECEPTORS AND OESTROGEN RECEPTORS IN HUMAN BREAST CANCERThe Lancet, 1985
- [9] Binding assays for epidermal growth factor1985
- Epidermal growth factor receptors in human breast cancerBreast Cancer Research and Treatment, 1984
- Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequencesNature, 1984
- A monoclonal antibody to the human epidermal growth factor receptorJournal of Cellular Biochemistry, 1982
- Epidermal Growth Factor Is a Major Growth-Promoting Agent in Human MilkScience, 1980
- Isolation and structure of urogastrone and its relationship to epidermal growth factorNature, 1975
- A simple, specific, radioisotopic assay for 5′-nucleotidaseAnalytical Biochemistry, 1975